"The Ascension St. John Clinical Research in Tulsa, Oklahoma, contributes to medical science by coordinating and conducting clinical trials and equipping our medical researchers with an efficient infrastructure and a committed research team. We help determine the safety and effectiveness of devices, diagnostic products, medications and treatment regimens intended for patient use. We also support our research teams with education programs and research funding. Our research study investigators are credentialed for clinical trials in their respective fields of medicine."

During the past decade, Ascension St John Clinical Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension St John Clinical Research Institute" #1 sponsor was "Cytokinetics" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Frank C Sciurba" with 1 trials sponsored, "HUYABIO International, LLC." with 1 trials sponsored and "Matthew Neal MD" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension St John Clinical Research Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Ji Xing Pharmaceuticals (Shanghai) Co., Ltd." with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ascension St John Clinical Research Institute" are "ASCVD" (1 trials), "Atrial Fibrillation" (1 trials), "COVID-19" (1 trials), "Carotid Stenosis" (1 trials) and "Coronavirus Disease 2019" (1 trials). Many other conditions were trialed in "Ascension St John Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Ascension St John Clinical Research Institute" are "Drug" (7 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban 2.5 MG" (1 trials), "Apixaban 5MG" (1 trials), "Aspirin" (1 trials) and "Bentracimab (PB2452) Infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ascension St John Clinical Research Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ascension St John Clinical Research Institute". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ascension St John Clinical Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension St John Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".